These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35134111)

  • 1. Anterior optic pathway pathology in CNS demyelinating diseases.
    Pisa M; Pansieri J; Yee S; Ruiz J; Leite MI; Palace J; Comi G; Esiri MM; Leocani L; DeLuca GC
    Brain; 2022 Dec; 145(12):4308-4319. PubMed ID: 35134111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.
    Manogaran P; Vavasour IM; Lange AP; Zhao Y; McMullen K; Rauscher A; Carruthers R; Li DKB; Traboulsee AL; Kolind SH
    Neuroimage Clin; 2016; 11():743-750. PubMed ID: 27330974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.
    Syc SB; Saidha S; Newsome SD; Ratchford JN; Levy M; Ford E; Crainiceanu CM; Durbin MK; Oakley JD; Meyer SA; Frohman EM; Calabresi PA
    Brain; 2012 Feb; 135(Pt 2):521-33. PubMed ID: 22006982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive Retinal and Optic Nerve Damage in a Mouse Model of Spontaneous Opticospinal Encephalomyelitis.
    Petrikowski L; Reinehr S; Haupeltshofer S; Deppe L; Graz F; Kleiter I; Dick HB; Gold R; Faissner S; Joachim SC
    Front Immunol; 2021; 12():759389. PubMed ID: 35140707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.
    Lucchinetti CF; Mandler RN; McGavern D; Bruck W; Gleich G; Ransohoff RM; Trebst C; Weinshenker B; Wingerchuk D; Parisi JE; Lassmann H
    Brain; 2002 Jul; 125(Pt 7):1450-61. PubMed ID: 12076996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss.
    Hadhoum N; Hodel J; Defoort-Dhellemmes S; Duhamel A; Drumez E; Zéphir H; Pruvo JP; Leclerc X; Vermersch P; Outteryck O
    Mult Scler; 2016 Apr; 22(5):649-58. PubMed ID: 26227005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.
    Marignier R; Nicolle A; Watrin C; Touret M; Cavagna S; Varrin-Doyer M; Cavillon G; Rogemond V; Confavreux C; Honnorat J; Giraudon P
    Brain; 2010 Sep; 133(9):2578-91. PubMed ID: 20688809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
    Manogaran P; Hanson JV; Olbert ED; Egger C; Wicki C; Gerth-Kahlert C; Landau K; Schippling S
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis.
    Naismith RT; Tutlam NT; Xu J; Klawiter EC; Shepherd J; Trinkaus K; Song SK; Cross AH
    Neurology; 2009 Mar; 72(12):1077-82. PubMed ID: 19307541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcystic inner nuclear layer abnormalities and neuromyelitis optica.
    Gelfand JM; Cree BA; Nolan R; Arnow S; Green AJ
    JAMA Neurol; 2013 May; 70(5):629-33. PubMed ID: 23529376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis.
    Vabanesi M; Pisa M; Guerrieri S; Moiola L; Radaelli M; Medaglini S; Martinelli V; Comi G; Leocani L
    Sci Rep; 2019 Jul; 9(1):10371. PubMed ID: 31316082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis.
    Idiman E; Ozakbaş S
    Expert Rev Neurother; 2011 Mar; 11(3):451-62. PubMed ID: 21375450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder.
    Pula JH; Kattah JC; Keung B; Wang H; Daily J
    J Neurol Sci; 2014 Oct; 345(1-2):209-12. PubMed ID: 25125046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optic neuropathy in positive anti-MOG antibody syndrome].
    Merabtene L; Vignal Clermont C; Deschamps R
    J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
    Jeong IH; Kim HJ; Kim NH; Jeong KS; Park CY
    J Neurol; 2016 Jul; 263(7):1343-8. PubMed ID: 27142716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features in anterior visual pathway in neuromyelitis optica.
    Hokari M; Yokoseki A; Arakawa M; Saji E; Yanagawa K; Yanagimura F; Toyoshima Y; Okamoto K; Ueki S; Hatase T; Ohashi R; Fukuchi T; Akazawa K; Yamada M; Kakita A; Takahashi H; Nishizawa M; Kawachi I
    Ann Neurol; 2016 Apr; 79(4):605-24. PubMed ID: 26836302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography.
    Pisa M; Ratti F; Vabanesi M; Radaelli M; Guerrieri S; Moiola L; Martinelli V; Comi G; Leocani L
    Mult Scler; 2020 Sep; 26(10):1197-1206. PubMed ID: 31392924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.